Imaging of the cisterna chyli on PET-CT in patients with known malignancy: Report of two cases

Similar documents
Appearance And Visibility Of The Thoracic Duct On Computed Tomography Of The Chest

Sectional Anatomy Quiz II

Sectional Anatomy Quiz - III

Imaging in gastric cancer

MR Lymphography of Abdominal and Retroperitoneal Lymphatic Vessels

STAGING AND FOLLOW-UP STRATEGIES

Thoracic duct and cisterna chyli: evaluation with multidetector row CT

Large veins of the thorax Brachiocephalic veins

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

Imaging of Gastrointestinal Stromal Tumors (GIST) Amir Reza Radmard, MD Assistant Professor Shariati hospital Tehran University of Medical Sciences

FDG PET/CT in Lung Cancer Read with the experts. Homer A. Macapinlac, M.D.

Journal of Medical Science & Technology

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

May 2017 Imaging Case of the Month. Prasad M. Panse, MD and Michael B. Gotway, MD. Department of Radiology Mayo Clinic Arizona Scottsdale, Arizona USA

Radiological Manifestations of Metastatic Melanoma

Returns fluids that leaked from blood vessels back to blood Consists of three parts

Boot Camp Case Scenarios

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

A pictorial review of normal anatomical appearences of Pericardial recesses on multislice Computed Tomography.

Division of Diagnostic Imaging, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

PET/CT Frequently Asked Questions

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review

SETTING Fudan University Shanghai Cancer Center. RESPONSIBLE PARTY Haiquan Chen MD.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Imaging Work-Up of a Neck Mass - Adults & Children

Mediastinal Tumors: Imaging

New Visions in PET: Surgical Decision Making and PET/CT

Postoperative Chylothorax: the Use of Dynamic Magnetic Resonance Lymphangiography and Thoracic Duct Embolization

Mediastinum It is a thick movable partition between the two pleural sacs & lungs. It contains all the structures which lie

The Lymphoid System Pearson Education, Inc.

PET CT for Staging Lung Cancer

Computed Tomography of Normal Adrenal Glands in Indian Population

Case Report PET/CT Imaging in Oncology: Exceptions That Prove the Rule

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

Radiology- Pathology Conference 4/29/2012. Lymph Nodes. John McGrath

11/1/2014. Radiologic incidentalomas Ordering pitfalls Newer technology and applications

Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer

CT abdomen and pelvis

Case Scenario #1 Larynx

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Radiology Pathology Conference

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

Dr. Weyrich G07: Superior and Posterior Mediastina. Reading: 1. Gray s Anatomy for Students, chapter 3

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh

PAPILLARY THYROID CARCINOMA PRESENTING AS A LATERAL NECK MASS MASS. Dr. Pamela Hanson DO PGY3

Kidney Case 1 SURGICAL PATHOLOGY REPORT

1 Normal Anatomy and Variants

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

A Pictorial Essay of the Diaphragmatic Crura and the Retrocrural Space: Normal Appearance, Variants and Pathology

INTERACTIVE SESSION 2

Preoperative Evaluation

STUDY OF AZYGOS SYSTEM AND ITS VARIATIONS B. Vijaya Nirmala 1, Teresa Rani S 2

IMAGING GUIDELINES - COLORECTAL CANCER

OBJECTIVE: To obtain a fundamental knowledge of the root of the neck with respect to structure and function

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Do you want to be an excellent Radiologist? - Focus on the thoracic aorta on lateral chest image!!!

Imaging Decisions Start Here SM

Pancreatic Adenocarcinoma: Everything You Need to Know From Cross-Sectional Imaging to Treatment

11/21/13 CEA: 1.7 WNL

PET in Rectal Carcinoma

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Role of CT imaging to evaluate solitary pulmonary nodule with extrapulmonary neoplasms

The Role of PET / CT in Lung Cancer Staging

Role of imaging in RCC. Ultrasonography. Solid lesion. Cystic RCC. Solid RCC 31/08/60. From Diagnosis to Treatment: the Radiologist Perspective

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

LYMPHATIC ANATOMY LAB. BIO 139 ANATOMY AND PHYSIOLOGY II MARY CATHERINE FLATH, Ph.D.

Case Scenario 1. History

CT Evaluation of Anomalies of the Inferior Vena Cava and Left Renal Vein

Testicular relapse of non-hodgkin Lymphoma noted on FDG-PET

Chapter 5: Other mediastinal structures. The Large Arteries. The Aorta. Ascending aorta

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

UCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives

Clinical summary. Male 30 year-old with past history of non-seminomous germ cell tumour. Presents with retroperitoneal lymphadenopathy on CT.

Case Report pissn J Korean Soc Radiol 2012;67(4): INTRODUCTION CASE REPORT

Learning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

Cardiovascular system:

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Lymphatic System and Immunity. Lymphatic System

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5)

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Glossary of Terms Primary Urethral Cancer

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Lung Perfusion Analysis New Pathways in Lung Imaging. Case Study Brochure PLA 309 Hospital

Images In Gastroenterology

ASSESSING THE PLAIN ABDOMINAL RADIOGRAPH M A A M E F O S U A A M P O F O

Fusion Ultrasound: Characterization of Abdominal Masses with MR, CT, PET, and Contrast Ultrasound

Cervical Cancer: 2018 FIGO Staging

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Transcription:

Imaging of the cisterna chyli on PET-CT in patients with known malignancy: Report of two cases Natalie Burns, B.S., Jason Barksdale, M.D., Linh Ho, M.D., and Patrick M. Colletti, M.D. Citation: Burns N, Barksdale J, Ho L, Colletti PM. Imaging of the cisterna chyli on PET-CT in patients with known malignancy: Report of two cases. Radiology Case Reports. [Online] 2009;4:269. Copyright: 2009 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License, which permits reproduction and distribution, provided the original work is properly cited. Commercial use and derivative works are not permitted. Abbreviations: CT, computed tomography; PET, positron emission tomography Natalie Burns, B.S. (Email: nburns@usc.edu), is at the Keck School of Medicine at the University of Southern California, Los Angeles, CA, United States of America. Jason Barksdale, M.D., Linh Ho, M.D., and Patrick M. Colletti, M.D., are in the Department of Radiology, Keck School of Medicine at the University of Southern California, Los Angeles, CA, United States of America. Published: March 5, 2009 DOI: 10.2484/rcr.v4i1.269 Abstract A normal cisterna chyli is a structure that may simulate retrocrural adenopathy on unenhanced CT. Our case report is significant because it highlights two cases in which patients with prior primary malignancies (medullary thyroid carcinoma, esophageal carcinoma) underwent PET-CT for restaging, and in each case, a prominent right retrocrural structure is seen representing either a cisterna chyli or retrocrural metastasis. The physiologic activity of the structure on PET-CT is considered and cross-sectional abdominal images are examined in full as well. In both cases, the structure has a low attenuation on CT and a low SUVmax on PET-CT, consistent with a benign process. These cases demonstrate that with the combined use of CT attenuation and PET SUVmax as guiding parameters, a cisterna chyli should be more readily distinguishable from retrocrural adenopathy, and thus can help to avoid unnecessary invasive management of the patient. Introduction The cisterna chyli is a dilated lymphatic sac that lies in the prevertebral space in a retrocrural position, most commonly at the L1-L2 vertebral level [1]. It serves as the origin of the thoracic lymphatic duct. Classically, the cisterna chyli receives lymphatic fluid from three lymphatic vessels: two lumbar lymphatic trunks deliver lymph from the lower extremities, and an intestinal trunk delivers fatty lymph from the intestines [2]. From the cisterna chyli, the lymph continues cephalad into the thoracic duct, ultimately draining into the venous system, usually via the internal jugular vein [1,3]. Imaging of the cisterna chyli has been described for lymphangiography, MRI, and CT. The prevalence with which the structure is visualized by each modality differs, from 52% with

lymphangiography, 96 % with MRI, to as low as 1.7% with CT [1,2,5]. We present two cases of known malignancy where the cisterna chyli is visualized with PET-CT. It is important to become familiar with the appearance of the cisterna chyli on PET-CT, to avoid confusing it with an enlarged retrocrural lymph node that might signify a recurrence of malignancy. Case Report 1 A 72-year-old male with a history of thyroid medullary carcinoma treated with surgical resection and radiation therapy was found to have a left paratracheal mass on MRI. This mass measured 3.8 x 2.9 x 7 cm, extending from the level of the true vocal cord, down to the level just above the aortic arch. As a follow-up to this finding, he underwent a PET-CT examination which revealed that the paratracheal mass was hypermetabolic, with an SUVmax of 14.9, suggesting a regional metastasis. Also visible was an active satellite node left and lateral to the paratracheal mass, a node in the anterior mediastinum adjacent to the innominate vein, and a 3 mm soft tissue nodule anterior to the vocal fold, suspicious for additional metastasis. A cross-sectional abdominal view revealed a hypo-attenuating, inactive, right retrocrural tubular shaped structure, at the T-12 vertebral level, compatible with the cisterna chyli. This structure displays attenuation nearly identical to the abdominal aorta, suggesting the presence of lymphatic fluid within, and it is also found to be within normal anatomical parameters, as described in previous studies of the cisterna chyli. On PET-CT, this structure was found to have an SUV max of 1.48, consistent with low metabolic activity. PET-CT, therefore, shows it to be physiologically inactive in comparison to the areas of tumor recurrence. (Figure 1).

Figure 1. Patient with history of thyroid medullary carcinoma. A, Unenhanced CT of abdomen. Note the attenuation value of the cisterna chyli, 16.8 HU, is within the normal range for fluid. The cisterna chyli appears adjacent and to the right of the abdominal aorta, posterior to the right crus of the diaphragm. Cisterna chyli = 1 Abdominal aorta = 2. Subcutaneous fat = 3. B, PET-CT of cisterna chyli shows an SUVmax of 1.48. Relatively low metabolic activity suggests that the cylindrical structure is not a malignant recurrence. Case Report 2 A 76-year-old male with a history of squamous esophageal carcinoma, treated with esophageal resection, gastric pull-through, local lymph node dissection, chemotherapy, and local radiation underwent PET-CT for surveillance of recurrence. PET-CT showed a right perigastric mass near the anastomosis measuring 2.7 x 2.0 x 3.3 cm (coronal, sagittal and vertical axes) with an SUVmax of 6.7, consistent with local recurrence. No evidence of focal disease was noted in the mediastinum or the periesophageal region, nor was any other abnormal activity visualized. On the concurrent CT, there is a prevertebral fluid-containing cyst at the level of T11, measuring 1.7 x 1.5 cm, without

activity on F-18 FDG PET. There is also a hypodense structure in the right retrocrural region at the level of T12 with an SUV max of 1.35 on PET, likely a cisterna chyli. The structure appears tubular with attenuation similar to the adjacent non-enhanced abdominal aorta. (Figure 2). Thus, PET-CT was able to confirm that the suspicious structure on CT was most likely benign, rather than a suspicious enlarged retrocural lymph node. Figure 2. Patient with a history of esophageal carcinoma. A,Non-enhanced CT of abdomen. Note the cisterna chyli (1), whose mean attenuation value of 10.4 HU is within the normal range for fluid. Cisterna chyli = 1 Abdominal aorta = 2. Subcutaneous fat = 3. B, PET-CT of cisterna chyli shows an SUVmax of 1.35. Low metabolic activity is suggestive of a non-malignant structure. Discussion The cisterna chyli is a normal structure that has a highly variable appearance. In our images, the cisterna chyli, as seen on PET-CT, falls within the normal parameters seen by lymphangiography, ultrasound, MR, and CT [1,4,5,7,8]. Rosenberger et al., in the first known study to characterize the cisterna chyli, reported it to lie most commonly at the L1 or L2 level (64%), while other investigators report it to lie in the prevertebral space at levels as far superior as T10 and as far inferior as L4 [2]. With regards to its shape, the cisterna chyli is quite variable in appearance. Some adhere to the idea that it is a true cisterna chyli only if it is in the form of the bullous, dilated, lymphatic pouch. Rosenberger found this classic configuration in 53% of the lymphangiographic images in his study [1]. Many others, however, have broadened the definition, referring to any structure immediately caudal to and continuous with the thoracic duct as the cisterna chyli, regardless of the presence or absence of an ampullar, dilated configuration [1,2,4]. The variant configurations, also first described by Rosenberger, were subsequently quantified by Pinto et al. in an MR study of 200 patients [4]. Sixty-seven percent of these patients exhibited single-vessel cisterna chyli, ranging from straight thin tubes to focal round collections. More complex arrangements, some of which consisted of two or more converging straight tubes, tortuous tubes, or focal plexuses, were noted in the remainder of the patients in this study [4]. With regards to its appearance on transverse abdominal imaging, the majority of previous studies of the retrocrural space demonstrate the cisterna chyli to be directly to the right of the abdominal aorta. An MR study of 125 patients, which demonstrated visible cisterna chyli in 96% of cases, showed 70% of them to have midline cisterna chyli, with 20% and 14.2% possessing

cisterna chyli to the right side or left side of the midline, respectively [2]. Thus, in looking at the characteristics of cisterna chyli as reported in the literature, we find that both patients in our report exhibit normal cisterna chyli. To date, the appearance of the cisterna chyli on PET-CT has not been fully described. As it is a normal structure, it is important to be familiar with its appearance before evaluating patients with known malignancies of the mediastinum or other locations that may potentially metastasize to retrocrural lymph nodes. This will help to avoid inadvertently interpreting the cisterna chyli as retrocrural adenopathy, which it can mimic on plain CT [8]. Past reports have suggested that retrocrural adenopathy could be distinguished from other normal retrocrural structures, based upon size alone. In fact, in a study of 151 patients who underwent CT scans, Callen et al. concluded that discrete retrocrural structures greater than six millimeters in diameter represent enlarged lymph nodes, while smaller retrocrural structures represent azygous veins or normal lymphatic structures, such as the cisterna chyli [6]. However, this idea was challenged by Smith and Grigorpoulos, who studied the incidence and characteristics of the cisterna chyli with CT. They found the diameter of the cisterna chyli to be greater than six millimeters in 86% of the studies [5]. Although their population was small (n=7), it highlights the importance of relying on parameters other than size in distinguishing cisterna chyli from retrocrural adenopathy. Our cases illustrate how PET-CT can diagnose the retrocrural structure in question as a normal cisterna chyli. Firstly, its identity, which is recognizable by the combination of its classic tubular shape, its position to the immediate right of the abdominal aorta, and its location at the T-12 vertebral level, can also be assured by its attenuation of 16.8 Hounsfield units (HU), a value to be expected of a lymphatic fluid-filled structure, since fluid attenuation values are generally between 0-20 HU. Secondly, in our cases, the retrocrural structures low FDG-PET SUVmax values of 1.5 and 1.3 respectively support the conclusion that these are indeed the cisterna chyli. In contrast to the low attenuation, low SUVmax cisterna chyle, Figure 3 demonstrates PET-CT in a comparison patient with rectal carcinoma and a metastatic retrocrural node (31 HU) with SUVmax = 5.0. The retrocrural SUVs of our cases are both very low in comparison to the SUVs of the respective malignant recurrences, 14.9 and 6.7, thus suggesting that they do not represent metastases.

Figure 3. Comparison case of a patient with a history of rectal carcinoma. A, Non-enhanced CT of abdomen shows a 2 cm retrocrural lymph node (arrow) with a mean attenuation of 31 HU. B, The retrocrural node (arrow) has an SUVmax of 5.0. References 1. Rosenberger A, Abrams HL. Radiology of the thoracic duct. Am J Roentgenol Radium Ther Nucl Med. 1971 Apr;111(4):807-20. [PubMed] 2. Erden A, Fitoz S, Yagmurlu B, Erden I. Abdominal confluence of lymph trunks: detectability and morphology on heavily T2-weighted images. AJR Am J Roentgenol. 2005 Jan;184(1):35-40. [PubMed] 3. Hayashi S, Miyazaki M. Thoracic duct: visualization at nonenhanced MR lymphography--initial experience. Radiology. 1999 Aug; 212(2):598-600. [PubMed]

4. Pinto PS, Sirlin CB, Andrade-Barreto OA. Cisterna chyli at routine abdominal MR imaging: a normal anatomic structure in the retrocrural space. Radiographics 24:809 817. [PubMed] 5. Smith T, Grigoropoulos J. The cisterna chyli: incidence and characteristics on CT. Clin Imaging 2000; 26;18-22. [PubMed] 6. Callen PW, Korobkin M, Isherwood I. Computed tomographic evaluation of the retrocrural prevertebral space. AJR Am J Roentgenol. 1977 Nov;129(5):907-10. [PubMed]. 7. Tamsel S, Ozbek SS, Sever A, Elmas N, Demirpolat G. Unusually large cisterna chyli: US and MRI findings. Abdom Imaging. 2006 Nov-Dec;31(6):719-21. Epub 2005 Dec 26. [PubMed] 8. Gollub MJ, Castellino RA. The cisterna chyli: a potential mimic of retrocrural lymphadenopathy on CT scans. Radiology. 1996 May; 199(2):477-80. [PubMed] This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License.